tldrdailynews.com logo

Eli Lilly's New Weight Loss Drug Advances to Late-Stage Trials After Promising Results

1 min read
Source: NBC News
Eli Lilly's New Weight Loss Drug Advances to Late-Stage Trials After Promising Results
Photo: NBC News
TL;DR

Eli Lilly's experimental obesity drug, eloralintide, shows promising results in mid-stage trials, with significant weight loss and improved health markers, leading to plans for late-stage trials and potential as an alternative to existing therapies.

Topics:businesshealth#amylin#eli-lilly#health#mid-stage-trial#obesity-drug#weight-loss
Share this article
  1. Lilly's new weight loss drug shows promise in mid-stage trial  NBC News
  2. Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study  CNBC
  3. Lilly moves obesity drug to late-stage trials after it shows promise  Reuters
  4. Eli Lilly’s Eloralintide Matches Zepbound’s Weight Loss in Mid-Stage Obesity Trial  Bloomberg.com
  5. Eli Lilly's next generation weight loss drug shows promise, early trial results suggest  abcnews.go.com

Want the full story? Read the original reporting

Read on NBC News